ID

24629

Description

Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT00483262

Link

https://clinicaltrials.gov/show/NCT00483262

Keywords

Versions (1)
  1. 8/10/17 8/10/17 -
Uploaded on

August 10, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Multiple Myeloma NCT00483262

English

Eligibility Multiple Myeloma NCT00483262

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years of age or older
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
must have received prior therapy for their myeloma and have relapsed and/or relapsed/refractory multiple myeloma
Description

Therapeutic procedure Myeloma | Recurrent disease | Multiple myeloma in relapse | Refractory multiple myeloma

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0026764
UMLS CUI [2]
C0277556
UMLS CUI [3]
C2349261
UMLS CUI [4]
C0278620
monoclonal protein in the serum of greater than or equal to 1 gm/dl or monoclonal light chain in the urine protein electrophoresis of greater than or equal to 200mg/24 hours, or measurable light chains by free light chain assay of greater than or equal to 10mg/dl, or measurable plasmacytoma
Description

Monoclonal protein Serum | Monoclonal free light chain present Urine protein electrophoresis | Immunoglobulin Light Chain Measurable Free Immunoglobulin Light Chain Assay | Plasmacytoma Measurable

Data type

boolean

Alias
UMLS CUI [1,1]
C0700271
UMLS CUI [1,2]
C0229671
UMLS CUI [2,1]
C1532998
UMLS CUI [2,2]
C0201721
UMLS CUI [3,1]
C0021038
UMLS CUI [3,2]
C1513040
UMLS CUI [3,3]
C0806492
UMLS CUI [3,4]
C1510438
UMLS CUI [4,1]
C0032131
UMLS CUI [4,2]
C1513040
ecog performance status 0, 1 or 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
laboratory values as outlined in the protocol
Description

Laboratory Results Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C2348563
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
uncontrolled infection
Description

Communicable Disease Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
cytotoxic chemotherapy less than 2 weeks, or biologic therapy less than 2 weeks, or corticosteroids less than 2 weeks prior to registration. patients may be receiving chronic corticosteroids if they are being given for disorders other than myeloma.
Description

Cytotoxic Chemotherapy | Biological treatment | Adrenal Cortex Hormones | Adrenal Cortex Hormones chronic | Myeloma Excluded

Data type

boolean

Alias
UMLS CUI [1]
C0677881
UMLS CUI [2]
C1531518
UMLS CUI [3]
C0001617
UMLS CUI [4,1]
C0001617
UMLS CUI [4,2]
C0205191
UMLS CUI [5,1]
C0026764
UMLS CUI [5,2]
C2828389
pregnant or nursing women
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
men or women of childbearing potential who are unwilling to employ adequate contraception
Description

Childbearing Potential Contraceptive methods Unwilling

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
other concurrent chemotherapy, immunotherapy, radiotherapy, or any ancillary therapy considered investigational within 14 days before enrollment
Description

Chemotherapy | Immunotherapy | Therapeutic radiology procedure | Investigational Therapy Ancillary

Data type

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C0021083
UMLS CUI [3]
C1522449
UMLS CUI [4,1]
C0949266
UMLS CUI [4,2]
C1549485
known to be hiv positive
Description

HIV Seropositivity

Data type

boolean

Alias
UMLS CUI [1]
C0019699
myocardial infarction within 6 months prior to enrollment or has nyha class iii or iv hear failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or electrocardiographic evidence of acute ischemia or active conduction system abnormalities
Description

Myocardial Infarction | Heart failure New York Heart Association Classification | Angina Pectoris Uncontrolled | Ventricular arrhythmia Severe Uncontrolled | Ischemia Electrocardiography | Conduction system abnormalities Electrocardiography

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2,1]
C0018801
UMLS CUI [2,2]
C1275491
UMLS CUI [3,1]
C0002962
UMLS CUI [3,2]
C0205318
UMLS CUI [4,1]
C0085612
UMLS CUI [4,2]
C0205082
UMLS CUI [4,3]
C0205318
UMLS CUI [5,1]
C0022116
UMLS CUI [5,2]
C1623258
UMLS CUI [6,1]
C0151236
UMLS CUI [6,2]
C1623258
hypersensitivity to bortezomib, boron or mannitol
Description

Hypersensitivity Bortezomib | Hypersensitivity Boron | Mannitol allergy

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1176309
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0006030
UMLS CUI [3]
C0571922
serious medical or psychiatric illness likely to interfere with participation in this clinical trial
Description

Illness Serious Interferes with Study Subject Participation Status | Serious mental illness Interferes with Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0521102
UMLS CUI [1,4]
C2348568
UMLS CUI [2,1]
C3841614
UMLS CUI [2,2]
C0521102
UMLS CUI [2,3]
C2348568
patients who may need or are receiving live vaccines for immunization
Description

Live Vaccines Immunization Patient need for | Live Vaccines Immunization

Data type

boolean

Alias
UMLS CUI [1,1]
C0042211
UMLS CUI [1,2]
C0020971
UMLS CUI [1,3]
C0686904
UMLS CUI [2,1]
C0042211
UMLS CUI [2,2]
C0020971
Back to the top of the page

Similar models

Eligibility Multiple Myeloma NCT00483262

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18 years of age or older
boolean
C0001779 (UMLS CUI [1])
Therapeutic procedure Myeloma | Recurrent disease | Multiple myeloma in relapse | Refractory multiple myeloma
Item
must have received prior therapy for their myeloma and have relapsed and/or relapsed/refractory multiple myeloma
boolean
C0087111 (UMLS CUI [1,1])
C0026764 (UMLS CUI [1,2])
C0277556 (UMLS CUI [2])
C2349261 (UMLS CUI [3])
C0278620 (UMLS CUI [4])
Monoclonal protein Serum | Monoclonal free light chain present Urine protein electrophoresis | Immunoglobulin Light Chain Measurable Free Immunoglobulin Light Chain Assay | Plasmacytoma Measurable
Item
monoclonal protein in the serum of greater than or equal to 1 gm/dl or monoclonal light chain in the urine protein electrophoresis of greater than or equal to 200mg/24 hours, or measurable light chains by free light chain assay of greater than or equal to 10mg/dl, or measurable plasmacytoma
boolean
C0700271 (UMLS CUI [1,1])
C0229671 (UMLS CUI [1,2])
C1532998 (UMLS CUI [2,1])
C0201721 (UMLS CUI [2,2])
C0021038 (UMLS CUI [3,1])
C1513040 (UMLS CUI [3,2])
C0806492 (UMLS CUI [3,3])
C1510438 (UMLS CUI [3,4])
C0032131 (UMLS CUI [4,1])
C1513040 (UMLS CUI [4,2])
ECOG performance status
Item
ecog performance status 0, 1 or 2
boolean
C1520224 (UMLS CUI [1])
Laboratory Results Study Protocol
Item
laboratory values as outlined in the protocol
boolean
C1254595 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Communicable Disease Uncontrolled
Item
uncontrolled infection
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Cytotoxic Chemotherapy | Biological treatment | Adrenal Cortex Hormones | Adrenal Cortex Hormones chronic | Myeloma Excluded
Item
cytotoxic chemotherapy less than 2 weeks, or biologic therapy less than 2 weeks, or corticosteroids less than 2 weeks prior to registration. patients may be receiving chronic corticosteroids if they are being given for disorders other than myeloma.
boolean
C0677881 (UMLS CUI [1])
C1531518 (UMLS CUI [2])
C0001617 (UMLS CUI [3])
C0001617 (UMLS CUI [4,1])
C0205191 (UMLS CUI [4,2])
C0026764 (UMLS CUI [5,1])
C2828389 (UMLS CUI [5,2])
Pregnancy | Breast Feeding
Item
pregnant or nursing women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Unwilling
Item
men or women of childbearing potential who are unwilling to employ adequate contraception
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Chemotherapy | Immunotherapy | Therapeutic radiology procedure | Investigational Therapy Ancillary
Item
other concurrent chemotherapy, immunotherapy, radiotherapy, or any ancillary therapy considered investigational within 14 days before enrollment
boolean
C0392920 (UMLS CUI [1])
C0021083 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0949266 (UMLS CUI [4,1])
C1549485 (UMLS CUI [4,2])
HIV Seropositivity
Item
known to be hiv positive
boolean
C0019699 (UMLS CUI [1])
Myocardial Infarction | Heart failure New York Heart Association Classification | Angina Pectoris Uncontrolled | Ventricular arrhythmia Severe Uncontrolled | Ischemia Electrocardiography | Conduction system abnormalities Electrocardiography
Item
myocardial infarction within 6 months prior to enrollment or has nyha class iii or iv hear failure, uncontrolled angina, severe uncontrolled ventricular arrhythmias, or electrocardiographic evidence of acute ischemia or active conduction system abnormalities
boolean
C0027051 (UMLS CUI [1])
C0018801 (UMLS CUI [2,1])
C1275491 (UMLS CUI [2,2])
C0002962 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0085612 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C0205318 (UMLS CUI [4,3])
C0022116 (UMLS CUI [5,1])
C1623258 (UMLS CUI [5,2])
C0151236 (UMLS CUI [6,1])
C1623258 (UMLS CUI [6,2])
Hypersensitivity Bortezomib | Hypersensitivity Boron | Mannitol allergy
Item
hypersensitivity to bortezomib, boron or mannitol
boolean
C0020517 (UMLS CUI [1,1])
C1176309 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0006030 (UMLS CUI [2,2])
C0571922 (UMLS CUI [3])
Illness Serious Interferes with Study Subject Participation Status | Serious mental illness Interferes with Study Subject Participation Status
Item
serious medical or psychiatric illness likely to interfere with participation in this clinical trial
boolean
C0221423 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,4])
C3841614 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
Live Vaccines Immunization Patient need for | Live Vaccines Immunization
Item
patients who may need or are receiving live vaccines for immunization
boolean
C0042211 (UMLS CUI [1,1])
C0020971 (UMLS CUI [1,2])
C0686904 (UMLS CUI [1,3])
C0042211 (UMLS CUI [2,1])
C0020971 (UMLS CUI [2,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial